Metformin Revisited

Unnikrishnan, R and Mohan, V (2016) Metformin Revisited. Diabetes Technology & Therapeutics, 18 (3). p. 113. ISSN 1520-9156

[img]
Preview
PDF
104Kb

Abstract

The explosive increase in the prevalence of type 2 diabetes (T2D) in recent decades has been paralleled by an almost equally dramatic increase in the number of therapeutic agents available for treating this condition. However, in spite of the development of several new classes of antidiabetes agents in recent years, metformin remains the firstline pharmacotherapeutic option for most cases of T2D, as per most national and international guidelines.1,2 It also finds use as an adjunct to insulin in gestational diabetes and diabetes complicating pregnancy.

Item Type:Article
Official URL/DOI:http://dx.doi.org/10.1089/dia.2016.0017
Uncontrolled Keywords:Metformin
Subjects:Diabetes
Divisions:Department of Diabetology
ID Code:971
Deposited By:surendar radha
Deposited On:07 Apr 2016 13:59
Last Modified:07 Apr 2016 13:59

Repository Staff Only: item control page